Autotransfusion Devices Market Segmentation:
Application Segment Analysis
The autotransfusion devices market is segmented and analyzed for demand and supply by application into orthopedic, cardiovascular, neurological, gynecological, obstetrics, and other surgeries. Out of all, the cardiovascular surgery segment is anticipated to hold the largest market size by the end of 2035. Increased instances of cardiovascular issues are creating higher demands for transplantation, surgery, and autotransfusion, which is likely to drive the growth of the segment. According to the World Health Organization, nearly 17.9 million people are dying of cardiovascular disease every year, and cardiovascular is the primary reason for most of the deaths in the world.
Product Type Segment Analysis
The autotransfusion devices market is segmented and analyzed for demand and supply by product type into autotransfusion systems, and accessories. Out of all, autotransfusion systems are expected to hold the highest market size by the end of 2035. Owing to their reliability in blood transfusion, autotransfusion systems are becoming more popular in both developed and emerging nations, which is predicted to propel expansion in this segment over the coming years. Furthermore, adaptability, transfusion reporting mechanisms, technological developments for enhanced clinical outcomes, and communication are predicted to propel the expansion of the dual-mode autotransfusion systems segment in the market by 2035. In November 2022, LivaNova US introduced the XtraTM autotransfusion system, which serves as a full blood management system. It combines three decades of expertise and advancements in cell salvage methods.
Our in-depth analysis of the global market includes the following segments:
|
By Application |
|
|
By Product Type |
|
|
By End User |
|
